Head-to-head · computed 2026-08-11
Direct Meds vs Elevate Health
Direct Meds: Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery. Elevate Health: Elevate Health sells compounded tirzepatide at $449 a month on its monthly plan or $263 a month on a prepaid 12-week program, with free blood work included and brand-name Zepbound also on the menu; its compounded semaglutide pricing spans a promotional band our desk has not resolved to a rankable maintenance figure.
Tirzepatide
| Direct Meds | Elevate Health | |
|---|---|---|
| All-in maintenance | $399/mo | $449/mo |
| Best plan rate | $399/mo | $263/mo |
| 12-month total | $4,788 | $5,388 |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Direct Meds's $399 a month undercuts Elevate Health's $449 by $50 a month at the 10 mg/wk maintenance basis — $600 across a year. Direct Meds's figure is reported (captured 2026-07-25) and Elevate Health's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's tirzepatide ladder runs $399 a month billed monthly. Elevate Health's runs $449 a month billed monthly, and $263 a month on a three-month plan. On the twelve-month basis Direct Meds's $4,788 beats Elevate Health's $5,388 by $600 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Direct Meds | Elevate Health | |
|---|---|---|
| All-in maintenance | $297/mo | not published |
| Best plan rate | $297/mo | — |
| 12-month total | $3,564 | — |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
Elevate Health does not publish a rankable maintenance-dose figure for semaglutide, so no winner can honestly be declared — a start-only price tells you what month one costs, not what the program costs.
Where the structures genuinely differ
On verifiability, Direct Meds names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Elevate Health's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice. On exit terms, Direct Meds's structure avoids prepaid lock-in while Elevate Health's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Direct Meds
- MembershipNone
- Dose policyAll-inclusive per format; injection and sublingual priced separately
- CommitmentMonthly (no commitment indicated)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Elevate Health
- MembershipNone
- Dose policyNot stated on captured materials
- CommitmentMonthly, or 12-week prepaid program
- CancellationPer published terms; 12-week program is prepaid — confirm refund terms at checkout
- PharmacyPartner pharmacy (unnamed on captured materials); clinical network via MDIntegra
What our desk is watching on each
Direct Meds: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
Elevate Health: Captures are dated (tirzepatide plan structure from a September 2025 consumer walkthrough; injectable band $233–$263 from January 2026 materials) — re-capture flagged. Three structural notes: checkout precedes medical qualification in the published flow (BMI ≥30, or ≥27 with a condition, gates approval after payment); the dispensing pharmacy is unnamed on captured materials, which fails this desk's verification workflow until answered; and the platform sells peptide add-ons (NAD+, glutathione) alongside GLP-1s — read the verification masterclass's add-on cautions before bundling. Not on the FDA's September 2025 warning-letter list per directory review; Trustpilot rating carries a review-solicitation flag.
Questions people ask
Is Direct Meds or Elevate Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Direct Meds vs Elevate Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Direct Meds and Elevate Health cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at Direct Meds and $5,388 at Elevate Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Direct Meds · Elevate Health. Official sites: Direct Meds ↗ · Elevate Health ↗. Nothing here is medical advice.